Logo

BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

Share this
BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

Shots:

  • DarwinHealth will receive an upfront and eligible to receive as a commercial milestone- as part of the NCTI collaboration
  • The focus of the collaboration is to identify NCTs across tumor subtypes for different cancer types by using quantitative systems biology-based algorithms- databases- and technologies and leads to the development of drugs with multi-subtype indications
  • Following the NCTs discovery- BMS gets the proprietary information from DarwinHealth in its drug databases- including specific tumor analyses from MRs or MRUMs of distinct tumor subtypes

  Ref: PRNewswire | Image: BMS

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions